US2017247329A1PendingUtilityA1
"Fluorinated Derivatives of 3-Hydroxypyridin-4-Ones"
Est. expiryJul 3, 2029(~3 yrs left)· nominal 20-yr term from priority
Inventors:Tim Fat TamRegis Leung-ToungYingsheng WangYanqing ZhaoTao XinBirenkumar ShahBlaise N'ZembaJolanta Maria WodzinskaMaryna Premyslova
A61P 35/00A61P 39/04A61P 25/00A61P 25/28A61P 13/00A61P 13/12A61P 11/00C07D 213/69C07D 211/88A61K 31/4412C07D 213/79C07D 211/86C07D 213/26C07D 401/06A61K 31/496A61K 31/4545C07D 213/74
54
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Compounds of Formula I which are derivatives of 3-Hydroxypyridin-4-ones. The compounds may be used in treatment of a medical condition related to a toxic concentration of iron. The compounds may be used for preparation of a medicament for treatment of a medical condition related to a toxic concentration of iron. The medical condition related to a toxic concentration of iron may be selected from the group consisting of: cancer, pulmonary disease, progressive kidney disease and Friedreich's ataxia.
Claims
exact text as granted — not AI-modified1 . A compound of Formula I:
wherein
G 1 is H, C 1 -C 4 alkyl or CH 2 OH;
G 2 is (CH 2 ) n CF 2 R 3 , where n is 1, and R 3 is H or F;
G 3 is H or Ci-C4 alkyl; and
G 4 is H.
2 . (canceled)
3 . The compound of claim 1 wherein R 3 is F.
4 .- 5 . (canceled)
6 . The compound of claim 3 wherein G 1 is ethyl, and G 3 is H.
7 .- 10 . (canceled)
11 . A method of treating a medical condition related to a toxic concentration of iron, wherein the method comprises administering to a subject having or suspected of having a medical condition related to a toxic concentration of iron, an effect amount of a compound of formula 1.
12 . The method of claim 11 wherein the medical condition related to a toxic concentration of iron is selected from the group consisting of cancer, pulmonary disease, progressive kidney disease and Friedreich's ataxia.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.